XRCC3 Gene Melanoma Cutaneous Malignant Familial Type 6 Susceptibility to Genetic Test sale cost 4400 AED
PTPN11 Gene Leukemia Juvenile Myelomonocytic Genetic Test sale cost 4400 AED PTPN11 Gene Leukemia Juvenile Myelomonocytic Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
MMR Genes Gene MMR Genes Methylation Analysis Genetic Test sale cost 4400 AED MMR Genes Gene MMR Genes Methylation Analysis Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

XRCC3 Gene Melanoma Cutaneous Malignant Familial Type 6 Susceptibility to Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The XRCC3 Gene Melanoma Cutaneous Malignant Familial Type 6 Susceptibility genetic test is a specialized diagnostic tool designed to assess an individual’s risk of developing familial type 6 cutaneous malignant melanoma, a type of skin cancer. This test focuses on identifying mutations in the XRCC3 gene, which plays a crucial role in DNA repair and maintaining genomic stability. Mutations in this gene can lead to an increased susceptibility to developing melanoma, a serious and potentially deadly form of skin cancer characterized by the uncontrolled growth of pigment-producing cells.

The test is performed at DNA Labs UAE, a state-of-the-art facility known for its advanced genetic testing capabilities. The cost of the test is 4400 AED, an investment in personal health that provides crucial information for individuals with a family history of melanoma or those at increased risk due to genetic factors. Early identification of susceptibility through this test can lead to proactive surveillance, early detection, and timely intervention, significantly improving outcomes for individuals at risk.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

XRCC3 Gene Melanoma cutaneous malignant familial type 6 susceptibility to Genetic Test

Components

Test Name: XRCC3 Gene Melanoma cutaneous malignant familial type 6 susceptibility to Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Cancer

Doctor: Oncologist

Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for XRCC3 Gene Melanoma, cutaneous malignant, familial type 6, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with XRCC3 Gene Melanoma, cutaneous malignant, familial type 6, susceptibility to NGS Genetic DNA Test gene XRCC3

Test Details

The XRCC3 gene is involved in DNA repair and plays a role in maintaining the stability of the genome. Mutations in this gene have been associated with an increased risk of developing certain types of cancer, including cutaneous malignant melanoma.

NGS (Next-Generation Sequencing) genetic testing is a technique that allows for the simultaneous analysis of multiple genes, including the XRCC3 gene, to identify any genetic variations or mutations. This type of testing can help determine an individual’s susceptibility to developing cutaneous malignant melanoma, familial type 6.

By analyzing the XRCC3 gene and other relevant genes, NGS genetic testing can provide valuable information about an individual’s genetic predisposition to melanoma. This information can be useful in guiding personalized screening, prevention, and treatment strategies for individuals at higher risk of developing this type of cancer.

Test Name XRCC3 Gene Melanoma cutaneous malignant familial type 6 susceptibility to Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for XRCC3 Gene Melanoma, cutaneous malignant, familial type 6, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with XRCC3 Gene Melanoma, cutaneous malignant, familial type 6, susceptibility to NGS Genetic DNA Test gene XRCC3
Test Details

The XRCC3 gene is involved in DNA repair and plays a role in maintaining the stability of the genome. Mutations in this gene have been associated with an increased risk of developing certain types of cancer, including cutaneous malignant melanoma.

NGS (Next-Generation Sequencing) genetic testing is a technique that allows for the simultaneous analysis of multiple genes, including the XRCC3 gene, to identify any genetic variations or mutations. This type of testing can help determine an individual’s susceptibility to developing cutaneous malignant melanoma, familial type 6.

By analyzing the XRCC3 gene and other relevant genes, NGS genetic testing can provide valuable information about an individual’s genetic predisposition to melanoma. This information can be useful in guiding personalized screening, prevention, and treatment strategies for individuals at higher risk of developing this type of cancer.

SKU: TEST-4522 Category:

Related products